Study Group: Current/Ongoing Studies
IMVT-1402-2701
Novartis CYTB323
Genentech GA45767
Study Name: Genentech GA45767 Phase 1, SLE Up to 15 LuCIN sites (U.S. and Canada) Active, Not recruiting
Study Name: Genentech GA45767 Phase 1, SLE Up to 15 LuCIN sites (U.S. and Canada) Active, Not recruiting